ARMITE LABORATORIES, INC. – Trademark Portfolio
Entity Type: 03
ARMITE LABORATORIES, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 4 (Lubricants & Fuels) — 5 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include 12|34, ARMITE, A ARMITE, and 12/34 MIRACLE FORMULA. The owner is based in COSTA MESA, CA.
1560 SUPERIOR AVENUE
SUITE A-4
COSTA MESA, CA 92627
Showing of trademarks Trademarks
Trademark Classifications
ARMITE LABORATORIES, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does ARMITE LABORATORIES, INC. have?
ARMITE LABORATORIES, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 cancelled.
What trademark classes does ARMITE LABORATORIES, INC. file in?
ARMITE LABORATORIES, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 4 (Lubricants & Fuels), Class 3 (Cosmetics & Cleaning), Class 2 (Paints). Class 4 covers industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions.
What are ARMITE LABORATORIES, INC.'s most well-known trademarks?
ARMITE LABORATORIES, INC.'s registered trademark portfolio includes well-known marks such as 12|34, ARMITE, A ARMITE, and 12/34 MIRACLE FORMULA. These are among 4 currently registered trademarks in the portfolio.
What is ARMITE LABORATORIES, INC.'s trademark registration success rate?
ARMITE LABORATORIES, INC. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.